Alector Inc (ALEC)

Alector Inc (ALEC) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $214M; returns 1 day +0.0%, 1 week -0.5%, 1 year +24.5%.

Alector Inc (ALEC) is a late-stage clinical biotechnology company specializing in immunotherapy treatments for neurodegenerative diseases, leveraging its proprietary microglia-based platform to develop antibodies that target neuroinflammation and support brain immune function.

Groups ALEC belongs to

• Biotechnology
• Neuroscience
• Immunotherapy
• Alzheimer's Disease
• Clinical Stage Biotech
• Healthcare
• CNS Disorders
• Antibody Therapeutics
• Clinical Stage

ALEC financial model: income statement, cash flow and balance sheet